Logo for Hamlet BioPharma

Hamlet BioPharma Investor Relations Material

Latest events

Logo for Hamlet BioPharma

Q3 2024

Hamlet BioPharma
Logo for Hamlet BioPharma

Q3 2024

24 May, 2024
Logo for Hamlet BioPharma

Q2 2024

22 Feb, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Hamlet BioPharma

Access all reports
Hamlet Pharma AB, a pharmaceutical company, engages in the research and development of cancer drugs. The company's lead product candidate is a patented drug that combines the active ingredient Bisantrene-Guanidinylpenicillamine in a galenic form suitable for oral administration. Its BAR treatment is administered through small pills that slowly release the active ingredient into the upper part of the gastrointestinal tract. The company is headquartered in Malmö, Sweden.